TargetMol

Indacaterol maleate

Product Code:
 
TAR-T1239
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1239-10mg10mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1239-25mg25mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1239-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1239-50mg50mg£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1239-100mg100mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1239-200mg200mg£189.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Indacaterol Maleate is an ultra-long-acting β-adrenoceptor agonist.
CAS:
753498-25-8
Formula:
C28H32N2O7
Molecular Weight:
508.571
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.9963
SMILES:
OC(=O)C=C/C(O)=O.CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Target:
Adrenergic Receptor

References

1. Battram C, et al. J Pharmacol Exp Ther, 2006, 317(2), 762-770. 2. Sturton RG, et al. J Pharmacol Exp Ther, 2008, 324(1), 270-275. 3. Naline E, et al. Eur Respir J, 2007, 29(3), 575-581. 4. Scola AM, et al. Br J Pharmacol, 2009, 158(1), 267-276. 5. Sayers I, et al. Br J Pharmacol, 2009, 158(1), 277-286.